In The News
Novaestiq’s Partner Croma-Pharma Announces Submission to the U.S. Food and Drug Administration for saypha® MagIQ™
21 Aug, 2024
Novaestiq Unveils Platform of Innovations; Poised to Disrupt the US Aesthetic Market
08 Jan, 2024
About Novaestiq
Novaestiq was founded in 2021 by Humberto Antunes, the former global CEO at Galderma and partner at Gore Range Capital, and Miles Harrison, former North American President at Galderma to bring innovative, first and best-in-class technology to the aesthetic market in North America.
Miles Harrison
Co-Founder, CEO & President
Drew Fine
Chief Commercial Officer
Nishan Patel
General Counsel & Head of Corporate Development
Humberto Antunes
Co-Founder & Board Chairman